Matches in Wikidata for { <http://www.wikidata.org/entity/Q96644069> ?p ?o ?g. }
- Q96644069 description "2020 nî lūn-bûn" @default.
- Q96644069 description "2020年の論文" @default.
- Q96644069 description "2020年学术文章" @default.
- Q96644069 description "2020年学术文章" @default.
- Q96644069 description "2020年学术文章" @default.
- Q96644069 description "2020年学术文章" @default.
- Q96644069 description "2020年学术文章" @default.
- Q96644069 description "2020年学术文章" @default.
- Q96644069 description "2020年學術文章" @default.
- Q96644069 description "2020年學術文章" @default.
- Q96644069 description "2020年學術文章" @default.
- Q96644069 description "2020年學術文章" @default.
- Q96644069 description "2020年學術文章" @default.
- Q96644069 description "2020년 논문" @default.
- Q96644069 description "article científic" @default.
- Q96644069 description "article scientific" @default.
- Q96644069 description "article scientifique" @default.
- Q96644069 description "articol științific" @default.
- Q96644069 description "articolo scientifico" @default.
- Q96644069 description "artigo científico" @default.
- Q96644069 description "artigo científico" @default.
- Q96644069 description "artigo científico" @default.
- Q96644069 description "artikel ilmiah" @default.
- Q96644069 description "artikull shkencor" @default.
- Q96644069 description "artikulong pang-agham" @default.
- Q96644069 description "artykuł naukowy" @default.
- Q96644069 description "artículo científico publicado en 2020" @default.
- Q96644069 description "artículu científicu" @default.
- Q96644069 description "bilimsel makale" @default.
- Q96644069 description "bài báo khoa học" @default.
- Q96644069 description "naučni članak" @default.
- Q96644069 description "scienca artikolo" @default.
- Q96644069 description "scientific article published on 23 June 2020" @default.
- Q96644069 description "scientific article published on 23 June 2020" @default.
- Q96644069 description "scientific article published on 23 June 2020" @default.
- Q96644069 description "teaduslik artikkel" @default.
- Q96644069 description "tieteellinen artikkeli" @default.
- Q96644069 description "tudományos cikk" @default.
- Q96644069 description "vedecký článok" @default.
- Q96644069 description "vetenskaplig artikel" @default.
- Q96644069 description "videnskabelig artikel udgivet 23. juni 2020" @default.
- Q96644069 description "vitenskapelig artikkel" @default.
- Q96644069 description "vitskapeleg artikkel" @default.
- Q96644069 description "vědecký článek" @default.
- Q96644069 description "wetenschappelijk artikel" @default.
- Q96644069 description "wissenschaftlicher Artikel" @default.
- Q96644069 description "επιστημονικό άρθρο" @default.
- Q96644069 description "мақолаи илмӣ" @default.
- Q96644069 description "наукова стаття, опублікована в червні 2020" @default.
- Q96644069 description "научна статия" @default.
- Q96644069 description "научная статья" @default.
- Q96644069 description "научни чланак" @default.
- Q96644069 description "научни чланак" @default.
- Q96644069 description "מאמר מדעי" @default.
- Q96644069 description "مقالة علمية نشرت في 23 يونيو 2020" @default.
- Q96644069 description "২৩ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96644069 description "บทความทางวิทยาศาสตร์" @default.
- Q96644069 description "სამეცნიერო სტატია" @default.
- Q96644069 name "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 name "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 type Item @default.
- Q96644069 label "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 label "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 prefLabel "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 prefLabel "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 P1433 Q96644069-78EEE1D3-1D71-49B7-9334-6FDF060C621E @default.
- Q96644069 P1476 Q96644069-5EE6AD5B-599F-45F3-850F-B10C000A9570 @default.
- Q96644069 P2093 Q96644069-0B469202-4E55-4180-89A9-6BF0C4A62E59 @default.
- Q96644069 P2093 Q96644069-0CB681EE-374D-4E35-AA7E-63E9E52EBC15 @default.
- Q96644069 P2093 Q96644069-14DEC904-1997-4767-95A5-1D00D10008B3 @default.
- Q96644069 P2093 Q96644069-1B8FB5EF-BD9C-4DCF-B2AF-3F8F501789FF @default.
- Q96644069 P2093 Q96644069-23251230-E8E7-4D95-AD49-21E079D05936 @default.
- Q96644069 P2093 Q96644069-2BF5C53B-C236-4B70-91B2-707E3B94BC0A @default.
- Q96644069 P2093 Q96644069-38B46464-EF88-4DCB-8B4D-824D7C584E5D @default.
- Q96644069 P2093 Q96644069-6026D2F3-1650-46DA-8BE3-37920BB05592 @default.
- Q96644069 P2093 Q96644069-60A0A760-E4F6-4F75-BCF5-D50CC33DA13D @default.
- Q96644069 P2093 Q96644069-8D8EAEAE-E3D5-449C-9DC5-53B10CD5794E @default.
- Q96644069 P2093 Q96644069-B673C4D3-CA12-4D9B-9BB6-10FCDC2F43D1 @default.
- Q96644069 P2093 Q96644069-CBFBFF64-6902-4FBC-97A0-644ADBB7FCCA @default.
- Q96644069 P2093 Q96644069-D08212BE-A9BA-4078-9E08-B4DCF80A9BA6 @default.
- Q96644069 P2093 Q96644069-D22EB4F0-0C7B-49F0-AA4F-24A7157D17E3 @default.
- Q96644069 P2093 Q96644069-D52F6049-08F3-4466-92CA-B2B4B66B4014 @default.
- Q96644069 P2093 Q96644069-D61DED01-05F1-45ED-A779-3A74F027F473 @default.
- Q96644069 P2093 Q96644069-F1D04693-B9CE-41BD-981A-687EEAB0E9B5 @default.
- Q96644069 P31 Q96644069-0919A72D-96DE-4E81-85D4-ABB690EFC0C2 @default.
- Q96644069 P356 Q96644069-2DC86062-604F-4222-9B3C-5940CDB13233 @default.
- Q96644069 P50 Q96644069-CAADFB31-3ECB-43F8-BD0F-8EC86779CDDB @default.
- Q96644069 P577 Q96644069-8B37C45F-FA18-4309-B421-D5FC7ACB970C @default.
- Q96644069 P698 Q96644069-72F3FC04-214A-4896-A2D3-0EE7E58C8D9B @default.
- Q96644069 P921 Q96644069-8178D172-C338-4364-8CA6-B6F67108FD6A @default.
- Q96644069 P356 S10637-020-00964-9 @default.
- Q96644069 P698 32578153 @default.
- Q96644069 P1433 Q2312231 @default.
- Q96644069 P1476 "Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B cell non-Hodgkin lymphoma" @default.
- Q96644069 P2093 "Andreas Berk" @default.
- Q96644069 P2093 "Andreas Viardot" @default.
- Q96644069 P2093 "Anne-Marie Quinson" @default.
- Q96644069 P2093 "Frank Kroschinsky" @default.
- Q96644069 P2093 "Georg Lenz" @default.
- Q96644069 P2093 "Gilles Salles" @default.